Emerging research links the gut microbiome to heart health. Beneficial bacteria may protect the heart, while others increase ...

Cardiol Therapeutics (NASDAQ:CRDL) used a presentation at TD Cowen’s 46th Annual Healthcare Conference to outline its clinical development programs targeting inflammation in cardiac disease, with its ...

Alnylam pens this deal with Tenaya as it looks to replicate the sales of its blockbuster ATTR-CM therapy, Amvuttra.

Genetic Heart Disease Targets with Alnylam’s Ability to Deliver Transformational Therapeutics Tenaya to Receive Up to $10 Million in Upfront Payments in Addition to Research Funding and Milestone ...

Lead candidate, EDIT-401, which demonstrated >90% mean LDL-C reduction in preclinical studies, remains on track for IND/CTA submission by mid-2026 ...

Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

Researchers from across the UK will come together to form a ground-breaking new research consortium focused on tackling inequalities in cardiovascular disease ...

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

On World Birth Defects Day, India's congenital anomalies burden is spotlighted with roughly 472,000 affected births annually, ...

Researchers at the University of Ottawa Heart Institute, the University of Ottawa and McGill University have launched ARCHIMEDES (Advanced Research Collaboration for Health Integration, Medical ...

The University of Bristol is one of nine UK universities included in a new £50 million 'Inequalities Challenge Consortium' launched by the National Institute for Health and Care Research (NIHR) to ...

The International Society for Stem Cell Research (ISSCR) proudly announces Kyle M. Loh, Stanford University School of Medicine, as the recipient of the 2026 ISSCR Early Career Impact Award, ...